Complete Response to Concurrent Triplet Therapy in Low‐Volume Metastatic Hormone‐Sensitive Prostate Cancer: A Case Report

ABSTRACT Introduction Triplet therapy with androgen deprivation therapy (ADT), an androgen receptor pathway inhibitor, and docetaxel improves survival in metastatic hormone‐sensitive prostate cancer (mHSPC), but its role in low‐volume disease remains unclear. Case Presentation A 68‐year‐old man pres...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Takashi Fujita, Koki Kobayashi, Gaku Hayashi, Shunsuke Kamijo, Fumihiro Ito
Format:	Artigo
Jezik:	Inglês
Izdano:	Wiley 2026-07-01
Serija:	IJU Case Reports
Teme:	complete response darolutamide docetaxel low‐volume disease metastatic hormone‐sensitive prostate cancer triplet therapy
Online dostop:	https://doi.org/10.1002/iju5.70231
Oznake:	Označite Brez oznak, prvi označite!